Guggenheim Capital’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Guggenheim Capital’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-293,962	Closed	-$7.08M	–	3280
2014 Q2	$7.08M	Sell	293,962 -166,665	-36%	-$1.74M	0.02%	1016
2014 Q1	$2.78M	Buy	+460,627	New	+$3.21M	0.01%	1512
2013 Q4	–	Sell	-10,134	Closed	-$53K	–	3335
2013 Q3	$53K	Buy	+10,134	New	+$44.4K	﹤0.01%	2932

Guggenheim Capital's IDIX Position: Q3 2014 in Review

Guggenheim Capital sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 293,962 shares — an estimated $7.08M sold.

Guggenheim Capital first reported a position in IDIX in Q3 2013 and held it in 3 quarters. The position peaked at $7.08M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Guggenheim Capital reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Guggenheim Capital sold 293,962 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $7.08M.
Guggenheim Capital first reported a position in IDENIX PHARMACEUTICALS INC in Q3 2013 and held it in 3 quarters.
Guggenheim Capital's IDENIX PHARMACEUTICALS INC position peaked at $7.08M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Guggenheim Capital's 13F filing for Q3 2014, filed 14 Nov 2014.